Adrian Yeung — ASN Events

Liverpool Hospital, NSW, Australia

Presentations this author is a contributor to:

Real-world experience with Dapagliflozin in people with type-2 diabetes living in Western Sydney: Beneficial impact on biomarkers and reasons for discontinuation. (#257)